Skip to NavigationSkip to content

News

0
Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as a...
0
A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still prescribing codeine, an opioid...
0
Roche has unveiled new Phase 3 efficacy data which showed strong findings for its immunotherapy Tecentriq in combination with Avastin and...
0
Novartis’s Tasigna (nilotinib) has received European Commission approval for the treatment of a specific subgroup of chronic myeloid leukemia in...

Features

Brian Woodfall, Global Head of Late Development, Infectious Diseases at Janssen, explains why a future without HIV can only be achieved if...